Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer

Table 2 Recurrence type in 139 patients of late recurrence

Site of recurrence	N
Contralateral breast	34
Local recurrence	27
Chest wall	9
Remnant breast	16
Axillary lymph node	2
Distant metastasis	78
Visceral metastasis (≥1 organ)^a	48
Non-visceral metastasis	30
Bone metastasis only	26
Multiple metastasis in non-visceral oragan^b	4

^aLung, liver, brain metastasis with or without bone metastasis
^bBone metastasis with lymph node metastasis such as internal mammary LN or subclavian LN

ISSN: 1471-2407